Tacrolimus and Danazol drug interactions - from FDA reports


Drug interactions are reported only by a few people who take Tacrolimus and Danazol together. This review analyzes the effectiveness and drug interactions between Tacrolimus and Danazol. It is created by eHealthMe based on reports of 5 people who take the same drugs from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.



On Feb, 10, 2019

5 people who take Tacrolimus, Danazol are studied.


Number of reports submitted per year:

Tacrolimus and Danazol drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Cardiac tamponade (fluid accumulates in heart covering)
  2. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  3. Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
  4. Infusion related reaction
1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Cytomegalovirus hepatitis (virus infection of liver)
  3. Gangrene (body tissue dies)
  4. Leukocytosis (increased white blood cells)
  5. Peripheral embolism (sudden interruption of blood flow to an organ or body part)

Most common drug interactions by gender *:

female:
  1. Cardiac tamponade (fluid accumulates in heart covering)
  2. Cytomegalovirus hepatitis (virus infection of liver)
  3. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  4. Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
  5. Infusion related reaction
  6. Leukocytosis (increased white blood cells)
male:
  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Gangrene (body tissue dies)
  3. Peripheral embolism (sudden interruption of blood flow to an organ or body part)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Cardiac tamponade (fluid accumulates in heart covering)
  2. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  3. Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
  4. Infusion related reaction
20-29:

n/a

30-39:

n/a

40-49:
  1. Cytomegalovirus hepatitis (virus infection of liver)
  2. Leukocytosis (increased white blood cells)
50-59:

n/a

60+:
  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Gangrene (body tissue dies)
  3. Peripheral embolism (sudden interruption of blood flow to an organ or body part)

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Danazol?


You are not alone:




Related studies

Tacrolimus

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. (latest outcomes from Tacrolimus 43,200 users)

Danazol

Danazol has active ingredients of danazol. It is often used in hereditary angioedema. (latest outcomes from Danazol 2,050 users)


Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Tacrolimus and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Danazol and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Tacrolimus and Danazol
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Tacrolimus and Danazol

FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!